Study of a new pill for weight loss in adults with obesity
Part of Hormones & metabolism clinical trials.
This trial tests a daily pill called KAI-7535 to see if it helps people with obesity or overweight lose weight safely. It is for adults who have a body mass index (BMI) of 27 or higher and at least one weight-related health problem, such as high blood pressure or type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition like high blood pressure, high cholesterol, sleep apnea, or heart disease.
- If you have type 2 diabetes, your BMI must be 27 or higher and your diabetes treatment must have been stable for at least 3 months.
- You cannot have lost or gained more than 5% of your body weight in the last 3 months without trying.
- You cannot have taken certain weight-loss or diabetes medications like Ozempic, Mounjaro, or similar drugs in the last 3 months.
- You must not have a history of pancreatitis, a rare thyroid tumor, or unstable heart problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.
This trial tests an investigational once-daily pill (ASC30) to see if it can help adults with overweight or obesity lose weight. You may be able to join if you have a high body mass index (BMI) and have tried to lose weight before.
This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.
This trial tests an investigational drug called BI 3034701 to see if it helps people lose weight. It is for adults who are obese or overweight with at least one weight-related health problem.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.